Review on the current trends of toxoplasmosis serodiagnosis in humans

RHD Ybañez, AP Ybañez, Y Nishikawa - Frontiers in cellular and …, 2020 - frontiersin.org
Toxoplasmosis is a widely distributed zoonotic infection caused by the obligate intracellular
apicomplexan parasite Toxoplasma gondii. It is mainly transmitted through the ingestion of …

Advances in serological, imaging techniques and molecular diagnosis of Toxoplasma gondii infection

A Rostami, P Karanis, S Fallahi - infection, 2018 - Springer
Background Toxoplasmosis is worldwide distributed zoonotic infection disease with medical
importance in immunocompromised patients, pregnant women and congenitally infected …

[HTML][HTML] Human Ocular Toxoplasmosis in Romania: History, Epidemiology, and Public Health: A Narrative Review

LA Ghenciu, OA Hațegan, SL Bolintineanu, AI Dănilă… - Microorganisms, 2024 - mdpi.com
Toxoplasmosis, caused by the protozoan parasite Toxoplasma gondii (T. gondii), presents a
significant global health concern, particularly for immunocompromised individuals and …

Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies

L Holec-Gąsior - Clinical and Vaccine Immunology, 2013 - Am Soc Microbiol
Toxoplasma gondii is a parasitic protozoan which is the cause of toxoplasmosis. Although
human toxoplasmosis in healthy adults is usually asymptomatic, serious disease can occur …

Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii

Y Wang, H Yin - Parasites & vectors, 2014 - Springer
Toxoplasma gondii is an obligate intracellular parasitic protozoan that has a wide host range
and causes a zoonotic parasitosis called toxoplasmosis. This infection causes significant …

Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice

J Guo, A Zhou, X Sun, W Sha, K Ai, G Pan… - Frontiers in …, 2019 - frontiersin.org
There is no effective protective vaccine against human toxoplasmosis, which is a potential
threat to nearly a third of the world population. Vaccines based on virus-like particles (VLPs) …

Peptide Microarray Analysis of In Silico-Predicted Epitopes for Serological Diagnosis of Toxoplasma gondii Infection in Humans

P Maksimov, J Zerweck, A Maksimov… - Clinical and Vaccine …, 2012 - Am Soc Microbiol
Toxoplasma gondii infections occur worldwide in humans and animals. In
immunocompromised or prenatally infected humans, T. gondii can cause severe clinical …

Chitosan Microsphere Used as an Effective System to Deliver a Linked Antigenic Peptides Vaccine Protect Mice Against Acute and Chronic Toxoplasmosis

J Guo, X Sun, H Yin, T Wang, Y Li, C Zhou… - Frontiers in Cellular …, 2018 - frontiersin.org
Multiple antigenic peptide (MAP) vaccines have advantages over traditional Toxoplasma
gondii vaccines, but are more susceptible to enzymatic degradation. As an effective delivery …

Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen

DF Qu, HJ Yu, Z Liu, DF Zhang, QJ Zhou… - Veterinary …, 2011 - Elsevier
Ginsenoside, the most important component isolated from Panax ginseng, exhibits a variety
of biological activities. Particularly, ginsenoside Rg1 is known to have immune-modulating …

Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis

E Torres-Morales, L Taborda, N Cardona… - Medical microbiology …, 2014 - Springer
We determined the specific lymphocyte proliferative response and cytokine profile
production regarding Toxoplasma P30 (2017 from virulent and non-virulent strain) and …